Lower mevalonate pyrophosphate decarboxylase activity is caused by the reduced amount of enzyme in stroke-prone spontaneously hypertensive rat

Journal of Biochemistry

Volumn 124, Issue 1, 1998, Pages 40-44

  Michihara, Akihiro ^a   Sawamura, Makoto ^a   Nara, Yasuo ^b   Ikeda, Katsumi ^a   Yamori, Yukio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF EAST ASIA   (Japan)

Author keywords

Cholesterol; Mevalonate pyrophosphate decarboxylase; Pravastatin; SHRSP

Indexed keywords

BRAIN ENZYME; CARBOXYLYASE; CHOLESTEROL; COLESTYRAMINE; DIPHOSPHOMEVALONATE DECARBOXYLASE; DIVALENT CATION; LIVER ENZYME; PRAVASTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PURIFICATION; HYPERTENSION; IMMUNOBLOTTING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; TISSUE LEVEL;

ANIMALIA;

EID: 0031849450     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a022094     Document Type: Article

References (26)

1. Okamoto, K., Yamori, Y., and Nagaoka, A. (1974) Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Cir. Res. 34/35, Suppl. 1, 143-153
2. Yamori, Y. (1977) in Gene-Environment Interaction in Common Diseases (Inoue, E. and Nishimura, H., eds.) pp. 141-154, University of Tokyo Press, Tokyo
3. Iritani, N., Fukuda, E., Nara, Y., and Yamori, Y. (1977) Lipid metabolism in spontaneously hypertensive rats (SHR). Atherosclerosis 28, 217-222
4. Neaton, J.D., Blockburn, H., Jacobs, D., Kuller, L., Lee, D.J., Sherwin, R., Shih, J., Stamler, J., and Wentworth, D. (1992) Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial: Multiple risk factor intervention trial research group. Arch. Int. Med. 157, 1490-1500
5. Yamori, Y., Nara, Y., Horie, R., Ohtaka, K., and Mitani, F. (1978) Biomembrane characteristics in stroke-prone spontaneously hypertensive rats (SHRSP). Jpn. Heart J. 19, 597-598
6. Yamori, Y., Nara, Y., Horie, R., and Ooshima, A. (1980) Abnormal membrane characteristics of erythrocytes in rat models and men with predisposition to stroke. Clin. Exp. Hypertens. 2, 1009-1021
7. Sawamura, M., Nara, Y., and Yamori, Y. (1992) Liver mevalonate 5-pyrophosphate decarboxylase is responsible for reduced serum cholesterol in stroke-prone spontaneously hypertensive rat. J. Biol. Chem. 267, 6051-6055
8. Kennelly, P.J. and Rodwell, V.W. (1985) Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by reversible phosphorylation-dephosphorylation. J. Lipid Res. 26, 903-914
9. Beg, Z.H., Stonik, J.A., and Brewer Jr., H.B. (1987) Modulation of the enzymic activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by multiple kinase systems involving reversible phosphorylation: a review. Metabolism 36, 900-917
10. Goldstein, J.L. and Brown, M.S. (1990) Regulation of the mevalonate pathway. Nature 343, 425-430
11. Ramachandran, C.K. and Shah, S.N. (1976) Decarboxylation of mevalonate pyrophosphate is one rate-limiting step in hepatic cholesterol synthesis in suckling and weaned rats. Biochem. Biophys. Res. Commun. 69, 42-47
12. Ramachandran, C.K. and Shah, S.N. (1977) Studies on mevalonate kinase, phosphomevalonate kinase and pyrophosphomevalonate decarboxylase in developing rat brain. J. Neurochem. 28, 751-757
13. Jabalquinto, A.M. and Cardemil, E. (1980) Secondary regulatory sites in rat liver cholesterol biosynthesis: role of 5-pyrophosphomevalonate decarboxylase. Lipids 15, 196-199
14. Jabalquinto, A.M. and Cardemil, E. (1981) The effect of diabetes, nutritional factors, and sex on rat liver and kidney mevalonate kinase, mevalonate-5-phosphate kinase, and mevalonate-5-pyrophosphate decarboxylase. Arch. Biochem. Biophys. 210, 132-139
15. Bloch, K., Chaykin, S., Phillips, A.H., and de Waard, A. (1959) Mevalonic acid pyrophosphate and isopentenylpyrophosphate. J. Biol. Chem. 234, 2595-2604
16. Dhe-Paganon, S., Magrath, J., and Abeles, R.H. (1994) Mechanism of mevalonate pyrophosphate decarboxylase: evidence for a carbocationic transition state. Biochemistry 33, 13355-13362
17. Skilleter, D.N. and Kekwick, R.G.O. (1971) The enzymes forming isopentenyl pyrophosphate from 5-phosphomevalonate (mevalonate 5-phosphate) in the latex of Hevea brasiliensis. Biochem. J. 124, 407-417
18. Popjak, G. (1969) Enzymes of sterol biosynthesis in liver and intermediates of sterol biosynthesis. Methods Enzymol. 15, 393-454
19. Chiew, Y.E., O'Sullivan, W.J., and Lee, C.S. (1987) Studies on pig liver mevalonate-5-diphosphate decarboxylase. Biochim. Biophys. Acta 916, 271-278
20. Shama Bhat, C. and Ramasarma, T. (1980) Purification & properties of mevalonate pyrophosphate decarboxylase of rat liver. Indian J. Biochem. Biophys. 17, 249-254
21. Toth, M.J., Huwyler, L., and Park, J. (1996) Purification of rat liver mevalonate pyrophosphate decarboxylase. Prep. Biochem. Biotechnol. 26, 47-51
22. Michihara, A., Sawamura, M., Nara, Y., Ikeda, K., and Yamori, Y. (1997) Purification and chracterization of two mevalonate pyrophosphate decarboxylases from rat liver: a novel molecular species of 37 kDa. J. Biochem. 122, 647-654
23. Alvear, M., Jabalquinto, A.M., Eyzaguirre, J., and Cardemil, E. (1982) Purification and characterization of avian liver mevalonate-5-pyrophosphate decarboxylase. Biochemistry 21, 4646-4650
24. Toth, M.J. and Huwyler, L. (1996) Molecular cloning and expression of the cDNAs encoding human and yeast mevalonate pyrophosphate decarboxylase. J. Biol. Chem. 271, 7895-7898
25. Duffard, R., Garcia, G., Rosso, S., Bortolozzi, A., Madariaga, M., diPaolo, O., and Evangelista-de-Duffard, A.M. (1996) Central nervous system myelin deficit in rats exposed to 2,4-dichlorophenoxyacetic acid throughout lactation. Neurotoxicol. Teratol. 18, 691-696
26. Matthies, H. Jr., Schulz, S., Hollt, V., and Krug, M. (1997) Inhibition by compactin demonstrates a requirement of isoprenoid metabolism for long-term potentiation in rat hippocampal slices. Neuroscience 79, 341-436